globenewswire news

BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

2026-05-19T12:00:00Z

SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate virtually in a fireside chat at A.G.P.'s Healthcare Company Showcase.

Fireside Chat Details:

Time: 11:40 AM ET
Date: Wednesday, May 20, 2026

Investors can register for the conference and view the fireside chat here.

About BioCardia^®

BioCardia, Inc., headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP^® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph^® vascular navigation product platforms. For more information visit: www.BioCardia.com.

CONTACT: Media Contact:
Miranda Peto, Investor Relations
Email: mpeto@BioCardia.com
Phone: 650-226-0120

Investor Contact:
David McClung, Chief Financial Officer
Email: investors@BioCardia.com
Phone: 650-226-0120

Articles

Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI

2026-05-19T13:04:36Z

MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Commure, the AI platform for healthcare, today announced $70 million in financing at a $7 billion post-money valuation. The round was...

Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain

2026-05-19T13:00:00Z

ALBANY, N.Y., May 19, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of its upgrade to its two...

Joshua Fritzler Named President of Olympia and Wesley Pharmaceuticals

2026-05-19T13:00:00Z

Executive promotion signals strategic growth and continued expansion of state-of-the-art 503A and 503B compounding operations

dacadoo and Bradesco Vida e Previdência Partner to Bring Digital Health Engagement to Millions in Brazil

2026-05-19T13:00:00Z

Zurich, Switzerland, May 19, 2026 (GLOBE NEWSWIRE) -- dacadoo, a Swiss-based global leader in customer engagement through its digital health engagement platform in preventative health, has entered a strategic partnership with Bradesco Vida e Previdência in Brazil.

NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration

2026-05-19T13:00:00Z

The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and reduced pain...

Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care

2026-05-19T13:00:00Z

Oura Members can take action on changes in sleep or breathing patterns through educational resources from Resmed and pathways for accessing care

SafeSpace Global Corp. (OTCID: SSGC) to Present at the Sidoti Micro-Cap Virtual Conference on May 21st

2026-05-19T13:00:00Z

Knoxville, TN., May 19, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation ("SafeSpace" or the "Company") (OTCID: SSGC), a provider of multimodal AI-powered physical safety and security technologies designed to enhance...

ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026

2026-05-19T13:00:00Z

Company continues expanding commercial presence across critical care markets

Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib

2026-05-19T12:45:00Z

HIGHLIGHTS

Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients

2026-05-19T12:45:00Z

Provides End-To-End Services for Preclinical & Clinical Projects with Extensive Experience in Decoding Biologics Production

Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21

2026-05-19T12:45:00Z

Sarasota, FL, May 19, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company"), a clinical-stage biopharmaceutical company pioneering neurological therapeutics, will present and host one-on-one meetings...

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial

2026-05-19T12:30:00Z

Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSD

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

2026-05-19T12:30:00Z

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward...

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

2026-05-19T12:30:00Z

Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall

HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network

2026-05-19T12:30:00Z

Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences’ ECG management platform

RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th

2026-05-19T12:30:00Z

MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a...

Prana IV Therapy Highlights Emerging Research on Magnesium’s Role in Stress and Neurological Function

2026-05-19T12:30:00Z

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- The global magnesium supplement market continues to grow (estimated at a 7–8% CAGR) as more consumers become concerned about magnesium deficiency, stress-related...

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

2026-05-19T12:24:00Z

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase...

Amplexd Therapeutics Initiates Phase 2 Clinical Trial of Investigational EGCg-Based HPV Therapy

2026-05-19T12:15:00Z

GAITHERSBURG, Md., May 19, 2026 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd”), a U.S.-based clinical-stage biotechnology company focused on women’s health and underserved therapeutic areas, today announced authorization from the...

NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment

2026-05-19T12:05:00Z

New sites in New Jersey, New York, and Florida broaden geographic reach and increase access for patients participating in Phase 2 trial of troculeucel in moderate Alzheimer’s disease.

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

2026-05-19T12:02:00Z

Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development strategy